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1-methyl, 4-phenyl, 1, 2, 3, 6-tetrahydropiridine (MPTP) is a neurotoxin, widely 
used to produce experimental models of Parkinson Disease in rodents and primates. 
Although dopaminergic neurons are the most sensitive to MPTP neurotoxicity, diff er-
ent neuronal subtypes could be aff ected. In particular, noradrenergic neurons of the 
Locus Coeruleus may be involved as well as nigral dopaminergic neurons. Moreover, 
apart from catecholamine-containing nuclei, recent studies indicate that MPTP may 
produce pathological eff ects within the spinal cord. This point deserves compelling 
interest since it suggests, at experimental level, commonalities between Parkinson 
Disease and Amyotrophic Lateral Sclerosis. For instance, recent reports demonstrate 
that MPTP activates apoptotic proteins at the level of spinal cord. However, to our 
knowledge, none of these studies so far analyzed whether motor neuron loss really 
occurs following MPTP administration. Therefore, in the present study we evaluat-
ed the eff ect of a robust dose of MPTP (20 mg/Kg X3) in the nigro-striatal system 
and spinal cord. Along with a severe dopaminergic cells loss within the substantia 
nigra, quantifi ed by stereology and a marked decrease of striatal catecholoamine fi b-
ers measured by semi-quantitative densitometry, we found a signifi cant (roughly 30 
%) depletion of motor neurons in the lumbar spinal cord of MPTP-treated C57BL/6J 
mice. At the same level, spared motor neurons often present an altered morphology, 
being dysmorphic and vacuolated. Furthermore, using four diff erent antibodies (tree 
monoclonal, one polyclonal), recognizing distinct epitopes in the sequence of alpha-
synuclein, we found that alpha-synuclein immunostaining is markedly altered in the 
spinal cord of MPTP-treated mice.
The present data shed new lights on similarities between dopaminergic neu-
rons and spinal motor neurons, while suggesting that MPTP might be a neurotoxin 
diverse from what originally considered.
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